This inventor holds 1 USPTO granted patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Reading. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2008
Title: The Innovations of Andrew C R Martin
Introduction
Andrew C R Martin is a notable inventor based in Ashtead, GB. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work has implications for therapeutic applications and advancements in medical science.
Latest Patents
One of Andrew C R Martin's key patents is related to a humanized antibody. The current invention provides new human variable chain framework regions and humanized antibodies comprising these framework regions. Additionally, the invention introduces a novel method for identifying framework acceptor regions in framework sequences, allowing for backmutation to graft a donor sequence to the human framework. This patent showcases his innovative approach to enhancing antibody efficacy.
Career Highlights
Throughout his career, Andrew C R Martin has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University of Reading. His experience in these institutions has allowed him to contribute to significant advancements in health and biotechnology.
Collaborations
Andrew has collaborated with esteemed colleagues such as Susanna M Rybak and Juergen Krauss. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Andrew C R Martin's contributions to the field of biotechnology, particularly through his patent on humanized antibodies, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile